CODA’s Shutdown and the State of the Market: What a LifeSci Search Report Reveals
LifeSci Search was recently featured in a BioSpace article titled, "In Tough Market, CODA Quietly Shuts Doors."
News | March 11, 2023
CODA Biotherapeutics, a Bay Area biotech company that was co-launched by Versant Ventures and MPM Capital in 2018, has closed down due to the tough economic conditions. The company was developing gene therapies for neurological disorders using chemogenetics. CODA is one of many life science companies that have faced layoffs or shutdowns in 2023 as the market becomes more challenging for pharma and biotech companies.
Ready to realize your future?